BRIEF — Sandoz Gets Canada Approval For Generic Semaglutide
Sept 18 (Reuters) — SANDOZ GROUP AG: Sandoz Receives Regulatory Approval For Generic Semaglutide In Canada, Paving Way To Expand Patient Access To Key Glp-1 Medicine Receives Regulatory Approval For Generic Semaglutide In Canada Health Canada Grants Marketing Authorisation For Sandoz Semaglutide Semaglutide Approved In